Document is current
Any future updates will be listed below
-
Authors
Bi, Xinyuan
Ma, Bin
Liu, Wei
Gao, Wei-Qiang
Ye, Jian
Rao, Hanyu https://orcid.org/0000-0003-1286-8707
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82203255, 82272054, W2431055)
Major Projects of Special Development Fund in Shanghai Zhangjiang National Independent Innovation Demonstration Zone (ZJ2021-ZD-007)
Shanghai Key Laboratory of Gynecologic Oncology, Shanghai Jiao Tong University (YG2024LC09)
Shanghai Jiao Tong University Trans-med Awards Research (STAR) Project (WF540162608)
Science and Technology Commission of Shanghai Municipality (24DIPA00300)
Sichuan Province Science and Technology Support Program (2024ZYD0112)
- License Information
-
More Information
Article History
Received: 3 October 2024
Accepted: 10 December 2024
First Online: 18 December 2024
Declarations
:
: This study was conducted at the School of Biomedical Engineering and Clinical Stem Cell Research Center, Shanghai Jiao Tong University. Approval was granted for a project titled “Cancer Immunotherapy Using Umbilical Cord Mesenchymal Stem Cells” in 2021 by the Renji Hospital Ethics Committee (No. KY2021-027). All participants provided informed consent.
: Not applicable.
: The authors declare no competing interests.
